Stem Cell Industry Puts Scotland in the Spotlight - Scotland's international acclaim for its stem cell research can be attributed to several factors, including a skilled workforce, government support,

ADVERTISEMENT

Stem Cell Industry Puts Scotland in the Spotlight
Scotland's international acclaim for its stem cell research can be attributed to several factors, including a skilled workforce, government support, and a top academic community.

BioPharm International


Stem cell research and manufacturing powerhouses, such as Stem Cell Sciences Ltd ( http://www.stemcellsciencesltd.com/), CXR Biosciences ( http://www.cxrbiosciences.com/), Invitrogen ( http://www.invitrogen.com/), Angel Biotechnology ( http://www.angelbio.com/), and Geron Corporation ( http://www.geron.com/), are prime examples of world-renowned companies conducting research in Scotland.

Also instrumental to Scotland's success is an organization that unites those interested in or conducting this type of research. The Scottish Stem Cell Network (SSCN, http://www.sscn.co.uk/), launched in 2003, brings together scientists and clinicians to improve the rate at which laboratory research translates into therapeutic benefits for patients. The SSCN works with the entire stem cell community in Scotland, including academic institutions and clinical and industry-based research groups, and also provides international organizations with easy access to stem cell researchers in Scotland. Another unique feature about the SSCN is the organization's role in engaging the general public to participate in open debates on issues deemed controversial with regards to this type of research.

Scotland is an ideal location in which to conduct stem cell research, with a powerful life sciences research and technology base and an equally supportive regulatory environment. Through advanced research led by globally respected stem cell experts and advanced facilities, Scotland is poised to continue to lead the way in the biomedical applications of cell biology.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
September 26, 2014
Author Guidelines
Source: BioPharm International,
Click here